Results of Eaga plc Shareholder Meetings

RNS Number : 8253D
Carillion PLC
29 March 2011
 

29 March 2011

 

 

CARILLION PLC

 

RECOMMENDED ACQUISITION OF EAGA PLC BY CARILLION PLC

 

RESULTS OF EAGA SHAREHOLDER MEETINGS AND FSA APPROVAL

 

 

 

Carillion plc ("Carillion") is pleased to note the announcement made by Eaga plc ("Eaga") regarding the passing of all resolutions and approval of the Scheme (as defined below) at the Eaga Court and General Meetings held in respect of the proposed acquisition to be made by Carillion of the entire issued and to be issued share capital of Eaga (the "Acquisition") which is being effected by way of a scheme of arrangement ("Scheme") between Eaga and its shareholders (other than Carillion, to the extent that it holds shares in Eaga) under Part 26 of the Companies Act 2006.

 

In addition, Carillion is pleased to announce that the FSA has notified Carillion that it has approved the application for a change in control of Eaga Insurance Services Limited.  Completion of the Acquisition remains subject to the satisfaction or (if capable of waiver) waiver of the remaining Conditions, including the sanction of the Scheme and the associated capital reduction by the Court.  The date of the hearing to sanction the Scheme, is expected to be 15 April 2011 and the hearing to confirm the capital reduction is expected to be 19 April 2011.  If the Court sanctions the Scheme and confirms the capital reduction, it is expected that the Scheme will become effective on 20 April 2011 and that the cancellation of the listing of Eaga Shares will take place by 8.00 a.m. on 21 April 2011.  If the Scheme does become effective on 20 April 2011, it is expected that the admission of the New Carillion Shares to trading on the London Stock Exchange's main market for listed securities will take effect on 21 April 2011.

 

The dates stated above are indicative only and will depend, among other things, on the dates upon which the Court sanctions the Scheme and confirms the associated capital reduction and the date on which the Conditions are satisfied or (if capable of waiver) waived.

 

Terms and expressions in this announcement shall, unless the context otherwise requires, have the same meanings as given to them in the document sent to Eaga shareholders in relation to the Scheme dated 4 March 2011.

 

Enquiries




Carillion plc

+44 (0)1902 422 431

John McDonough, Chief Executive

Richard Adam, Group Finance Director

John Denning, Director Group Corporate Affairs

 

 

+44 (0)1902 316426



Lazard & Co., Limited (Financial Adviser)

+44 (0)20 7187 2000

Nicholas Shott

Cyrus Kapadia

Vasco Litchfield




Morgan Stanley & Co. International plc (Joint Corporate Broker)

+44 (0)20 7425 8000

Peter Moorhouse

Alastair Walmsley




Oriel Securities Limited (Joint Corporate Broker)

+44 (0)20 7710 7600

David Arch




Finsbury (PR Adviser)

+44 (0)20 7251 3801

James Murgatroyd

Gordon Simpson


 

Lazard, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Carillion and no one else in connection with the Acquisition and this announcement, and will not be responsible to anyone other than Carillion for providing the protections afforded to clients of Lazard nor for providing advice in connection with the Acquisition or this announcement or any matter referred to herein.

 

Morgan Stanley & Co. International plc is acting as corporate broker exclusively for Carillion and no one else in connection with the Acquisition and this announcement, and will not be responsible to anyone other than Carillion for providing the protections afforded to clients of Morgan Stanley & Co. International plc nor for providing advice in connection with the Acquisition or this announcement or any matter referred to herein.

 

Oriel Securities, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Carillion and no one else in connection with the Acquisition and this announcement, and will not be responsible to anyone other than Carillion for providing the protections afforded to clients of Oriel Securities nor for providing advice in connection with the Acquisition or this announcement or any matter referred to herein.

 

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in any such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions. 

 

This announcement is not intended to, and does not constitute, or form part of, an offer to sell or any invitation to purchase or subscribe for any securities or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise. This announcement does not constitute a prospectus or a prospectus equivalent document. Shareholders of Carillion and Eaga are advised to read carefully the formal documentation in relation to the Acquisition. The proposals for the Acquisition are being made solely through the Scheme Document, which contains the full terms and conditions of the Scheme. Eaga Shareholders may obtain a further free copy of the Scheme Document from DLA Piper UK LLP at 3 Noble Street, London, EC2V 7EE.

 

THIS ANNOUNCEMENT IS NOT A PROSPECTUS. IT DOES NOT CONSTITUTE OR FORM PART OF AN OFFER TO SELL OR ANY INVITATION TO PURCHASE OR SUBSCRIBE FOR ANY SECURITIES OR THE SOLICITATION OF AN OFFER TO PURCHASE, OTHERWISE ACQUIRE, SUBSCRIBE FOR, SELL OR OTHERWISE DISPOSE OF ANY SECURITIES OR THE SOLICITATION OF ANY VOTE OR APPROVAL IN ANY JURISDICTION PURSUANT TO THE ACQUISITION OR OTHERWISE. ANY ACCEPTANCE OR RESPONSE TO THE ACQUISITION SHOULD BE MADE ONLY ON THE BASIS OF THE INFORMATION REFERRED TO IN THE SCHEME DOCUMENT AND THE PROSPECTUS.

 

1.         Overseas Jurisdictions

 

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by the laws of those jurisdictions and therefore persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Failure to comply with any such restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

In particular, this announcement is not an offer of securities for sale in the United States and the New Carillion Shares, which will be issued in connection with the Acquisition, have not been, and will not be, registered under the US Securities Act or under the securities law of any state, district or other jurisdiction of the United States, and no regulatory clearance in respect of the New Carillion Shares has been, or will be, applied for in any jurisdiction other than the UK. The New Carillion Shares may not be offered or sold in the United States absent registration under the US Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. The New Carillion Shares will be issued in reliance (if required) upon the exemption from the registration requirements of the US Securities Act provided by Section 3(a)(10) thereof. The New Carillion Shares may not be offered, sold, resold, delivered or distributed, directly or indirectly, in, into or from any Restricted Jurisdiction (as defined in the Prospectus) or to, or for the account or benefit of, any resident of any Restricted Jurisdiction absent an exemption from registration or an exemption under relevant securities law.

 

Notice to US investors in Eaga: The Acquisition relates to the shares of a UK company and is proposed to be made by means of a scheme of arrangement provided for under the laws of England and Wales. The Acquisition is subject to the disclosure requirements and practices applicable in the United Kingdom to schemes of arrangement, which differ from the disclosure and other requirements of US securities laws. Financial information included in the relevant documentation will have been prepared in accordance with accounting standards applicable in the United Kingdom that may not be comparable to the financial statements of US companies.

 

If the Acquisition is implemented by way of an Offer, it will be made in accordance with the procedural and filing requirements of the US securities laws, to the extent applicable. If the Acquisition is implemented by way of an Offer, the New Carillion Shares to be issued in connection with such offer will not be registered under the US Securities Act or under the securities laws of any state, district or other jurisdiction of the United States and may not be offered or sold in the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act or such other securities laws. Carillion does not intend to register any such New Carillion Shares or part thereof in the United States or to conduct a public offering of the New Carillion Shares in the United States.

 

2.         Publication on Carillion Website

 

A copy of this announcement will be made available for inspection on Carillion's website (www.carillionplc.com) free of charge.

 

END

 

 

507388553


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSESFFUFFSEFD

Companies

Carillion (CLLN)
UK 100

Latest directors dealings